Pain profiling in migraine: a systematic review of Quantitative Sensory Testing (QST), Conditioned Pain Modulation (CPM), and Corneal Confocal Microscopy (CCM)
- PMID: 39701963
- PMCID: PMC11660458
- DOI: 10.1186/s10194-024-01932-x
Pain profiling in migraine: a systematic review of Quantitative Sensory Testing (QST), Conditioned Pain Modulation (CPM), and Corneal Confocal Microscopy (CCM)
Abstract
Objective: The aim of this systematic review is to identify pain profiling parameters that are reliably different between patients with migraine and healthy controls, using Quantitative Sensory Testing (QST) including Temporal Summation (TS), Conditioned Pain Modulation (CPM), and Corneal Confocal Microscopy (CCM).
Methods: A comprehensive literature search was conducted (up to 23 May 2024). The quality of the research was assessed using the Newcastle-Ottawa Scale (NOS) for non-randomized studies.
Results: Twenty-eight studies were included after screening. The QST studies indicate that migraine patients exhibit lower pressure pain thresholds (PPT), particularly in the trigeminal region. A previous meta-analysis reported lower heat pain thresholds (HPT). CPM studies suggest a (mild) inhibitory or absent response in migraine patients, not different from controls. High-frequency and chronic migraine patients may exhibit a facilitatory CPM response. With repeated executions of CPM, migraine patients display a diminishing CPM response, a phenomenon not observed in control subjects. CCM investigations in migraine patients revealed conflicting outcomes, likely as a result of small sample sizes and limited characterization of migraine features.
Conclusion: Pain profiling migraine patients varies due to sensory modality, applied methods, anatomical sites, and migraine features. Understanding pain profiling offers insights into migraine pathophysiology, requiring careful selection of parameters and differentiation among migraine subtypes.
Keywords: Allodynia; Chronic migraine (CM); Conditioned Pain Modulation (CPM); Corneal Confocal Microscopy (CCM); Episodic migraine (EM); Migraine; Pain profile; Psychophysical measure; Quantitative Sensory Testing (QST).
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures


Similar articles
-
What a Sham(e): Sham-Controlled Conditioned Pain Modulation Effects on Pressure but Not Heat Pain Thresholds in Healthy Volunteers.Eur J Pain. 2025 Jul;29(6):e70067. doi: 10.1002/ejp.70067. Eur J Pain. 2025. PMID: 40590843 Free PMC article.
-
Quantitative Sensory Testing in an Observational Cohort of Adults With Chronic Low Back Pain.JOR Spine. 2025 Aug 19;8(3):e70103. doi: 10.1002/jsp2.70103. eCollection 2025 Sep. JOR Spine. 2025. PMID: 40837129 Free PMC article.
-
Increased pain sensitivity but normal pain modulation in adolescents with migraine.Pain. 2019 May;160(5):1019-1028. doi: 10.1097/j.pain.0000000000001477. Pain. 2019. PMID: 30624343
-
Botulinum toxins for the prevention of migraine in adults.Cochrane Database Syst Rev. 2018 Jun 25;6(6):CD011616. doi: 10.1002/14651858.CD011616.pub2. Cochrane Database Syst Rev. 2018. PMID: 29939406 Free PMC article.
-
Acupuncture for the prevention of episodic migraine.Cochrane Database Syst Rev. 2016 Jun 28;2016(6):CD001218. doi: 10.1002/14651858.CD001218.pub3. Cochrane Database Syst Rev. 2016. PMID: 27351677 Free PMC article.
References
-
- Argaman Y, Kisler LB, Granovsky Y, Coghill RC, Sprecher E, Manor D, Weissman-Fogel I (2020) The endogenous analgesia signature in the resting brain of healthy adults and migraineurs. J Pain 21(7–8):905–918 - PubMed
-
- Ashina M, Terwindt GM, Al-Karagholi MA, de Boer I, Lee MJ, Hay DL, Schulte LH, Hadjikhani N, Sinclair AJ, Ashina H, Schwedt TJ, Goadsby PJ (2021) Migraine: disease characterisation, biomarkers, and precision medicine. Lancet 397(10283):1496–1504 - PubMed
-
- Ashina S, Melo-Carrillo A, Szabo E, Borsook D, Burstein R (2023) Pre-treatment non-ictal cephalic allodynia identifies responders to prophylactic treatment of chronic and episodic migraine patients with galcanezumab: a prospective quantitative sensory testing study (NCT04271202). Cephalalgia 43(3):3331024221147881 - PubMed
-
- Ashina S, Terwindt GM, Steiner TJ, Lee MJ, Porreca F, Tassorelli C, Schwedt TJ, Jensen RH, Diener HC, Lipton RB (2023) Medication overuse headache. Nat Rev Dis Primers 9(1):5 - PubMed
-
- Barone M, Imaz F, De la Torre Canales G, Venosta M, Dri J, Intelangelo L (2024) Somatosensory and psychosocial profile of migraine patients: a cross-sectional study. Musculoskelet Sci Pract 70:102924 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical